J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from its acquisition of Intra-Cellular Therapies. It maintained its full-year ...

The much-publicized introduction of genetically modified cubs that share features of extinct dire wolves sparked claims ...

Bipartisan congressional commission introduces legislation to coordinate emerging biotechnology research and boost investment ...

Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf species that died out more than 10,000 years ago, in April 2025. Three pups ...

Michael Kratsios, the newly-confirmed director of tech and science policy, introduced a strategy to boost American innovation through deregulation and ...

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...

U.S. stocks rose with the Dow up 312 points as tech products like phones and chips were excluded from tariffs. Global markets followed suit with strong biotech and real estate sectors. Treasuries ...

Ohio political campaigns are following a different rulebook. Just look at the governor's race between Vivek Ramaswamy and Dave Yost.

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...

President Donald Trump on Monday reiterated his plans to impose levies in the “not too distant future” against pharmaceutical ...

As nearly 800,000 Americans face death or permanent disability each year due to diagnostic errors?with women and minorities 30% more likely to be misdiagnosed than white men?it's clear that the U.S.